BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11198618)

  • 1. The renin angiotensin system in bypass graft surgery.
    Borland JA; Chester AH; Yacoub MH
    Curr Opin Cardiol; 2000 Nov; 15(6):371-7. PubMed ID: 11198618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts.
    Borland JA; Chester AH; Crabbe S; Parkerson JB; Catravas JD; Yacoub MH
    J Thorac Cardiovasc Surg; 1998 Aug; 116(2):206-12. PubMed ID: 9699571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
    Roks A; Buikema H; Pinto YM; van Gilst WH
    Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and the endothelium: diverse signals and effects.
    Watanabe T; Barker TA; Berk BC
    Hypertension; 2005 Feb; 45(2):163-9. PubMed ID: 15630047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of the renin-angiotensin system in heart failure.
    Kim SD
    Biol Res Nurs; 2000 Jan; 1(3):210-26. PubMed ID: 11232216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The renin-angiotensin system: systemic and local function].
    Gohlke P; Ganten D; Lang RE; Unger T
    Z Kardiol; 1988; 77 Suppl 3():1-12. PubMed ID: 2850684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
    Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
    Völzke H; Kleine V; Robinson DM; Grimm R; Hertwig S; Schwahn C; Eckel L; Rettig R
    Int J Cardiol; 2005 Jan; 98(1):133-9. PubMed ID: 15676177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery.
    Nishimoto M; Takai S; Sawada Y; Yuda A; Kondo K; Yamada M; Jin D; Sakaguchi M; Asada K; Sasaki S; Miyazaki M
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):729-34. PubMed ID: 11279415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The renin-angiotensin system of the brain].
    Wiecek A
    Pol Arch Med Wewn; 1983 Jan; 69(1):69-78. PubMed ID: 6310531
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting.
    van der Harst P; Volbeda M; Voors AA; Buikema H; Wassmann S; Böhm M; Nickenig G; van Gilst WH
    Hypertension; 2004 Dec; 44(6):930-4. PubMed ID: 15505113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease.
    Rueckschloss U; Quinn MT; Holtz J; Morawietz H
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1845-51. PubMed ID: 12426214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].
    Huber K; Pachinger O; Pichler M; Klein W
    Z Kardiol; 1997 Apr; 86(4):239-50. PubMed ID: 9235795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts about the renin angiotensin system: present and future clinical applications.
    McLigeyo SO
    East Afr Med J; 1996 Sep; 73(9):607-10. PubMed ID: 8991244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of functional angiotensin II receptor and angiotensin converting enzyme in the aorta of the snake Bothrops jararaca.
    Esteves CA; Burckhardt PL; Breno MC
    Life Sci; 2012 Nov; 91(19-20):944-50. PubMed ID: 23000029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
    Dzau VJ
    Basic Res Cardiol; 1993; 88 Suppl 1():1-14. PubMed ID: 8395169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ovarian renin-angiotensin system in reproductive physiology.
    Yoshimura Y
    Front Neuroendocrinol; 1997 Jul; 18(3):247-91. PubMed ID: 9237079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.